✦ LIBER ✦

A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis

✍ Scribed by Neil K. Singla; Jeffrey L. Ballard; Gregory Moneta; C. Duane Randleman Jr; Kenneth L. Renkens; W. Allan Alexander

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase 3, Randomized, Double-Blind Comp

✍ William C. Chapman; Neil Singla; Yuri Genyk; James W. McNeil; Kenneth L. Renkens 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 228 KB

5:3776. Safety, tolerability, and immuno

✍ Neil Singla; Sonia Singla; Jonathan Horne; Harry Lockstadt; Walter Krengel; Jeff 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Safety and immunogenicity of the recombi

✍ Grode, Leander; Ganoza, Christian A.; Brohm, Christiane; Weiner, January; Eisele 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Safety and immunogenicity of a trivalent

✍ M. Loebermann; G. Anders; G. Brestrich; C. Fritzsche; S. Klammt; D. Boršo; S. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 267 KB

An open-label, single-arm, phase I study

✍ Namhee Kim; Gyoungjin Choi; Chi-Yeon Lim; Jae-Won Lee; Kyung-Hyo Kim; Hoan Jong 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 367 KB

Efficacy and safety of a microsomal trig

✍ Cuchel, Marina; Meagher, Emma A; du Toit Theron, Hendrik; Blom, Dirk J; Marais, 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 222 KB